B39.2
Pulmonary histoplasmosis capsulati, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Pulmonary histoplasmosis capsulati is a fungal infection caused by the Histoplasma capsulatum fungus, primarily affecting the lungs. It is often contracted through inhaling spores found in environments contaminated with bird or bat droppings. Symptoms can range from mild to severe, and while some individuals remain asymptomatic, others may experience significant respiratory issues. Proper awareness and recognition of the condition are important for timely diagnosis and management, although treatment approaches vary depending on severity.
Causes & Symptoms
Clinical Causes: Inhalation of airborne spores of Histoplasma capsulatum, especially in areas with contaminated soil containing bird or bat droppings Occupational exposure in environments such as caves, poultry houses, or construction sites where spores may be present Environmental factors that increase spore dispersion, such as dust during excavation or demolition activities
Key Symptoms: Persistent cough Fever and chills Chest pain or discomfort Shortness of breath Fatigue or tiredness Night sweats Muscle or joint aches Weight loss in more severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosing pulmonary histoplasmosis involves a combination of clinical evaluation, imaging studies, and laboratory tests. Physicians may recommend chest X-rays to observe lung abnormalities often seen in fungal infections. Laboratory tests might include blood cultures, antigen detection, or antibody testing to identify the presence of Histoplasma capsulatum. In some cases, lung tissue sampling may be required to confirm the diagnosis. Due to similarity with other respiratory conditions, a thorough diagnostic process is crucial.
Treatment Protocols: Treatment of pulmonary histoplasmosis varies based on the severity of the illness. Mild cases may resolve on their own with rest and supportive care. More severe or persistent infections typically require antifungal medications such as itraconazole or amphotericin B. Managing symptoms and preventing complications are important aspects of care. In immunocompromised individuals, prompt and aggressive treatment may be necessary to control the infection and prevent dissemination.
Clinical Advice & FAQs
Billing Guidance
Is B39.2 a billable ICD-10 code?
Yes, B39.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B39.2?
Clinical documentation must specify the nature of Pulmonary histoplasmosis capsulati, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
